X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES PIRAMAL ENTERPRISES JUBILANT LIFE SCIENCES/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 26.2 39.3 66.6% View Chart
P/BV x 5.4 3.3 164.5% View Chart
Dividend Yield % 0.3 0.7 45.4%  

Financials

 JUBILANT LIFE SCIENCES   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
PIRAMAL ENTERPRISES
Mar-17
JUBILANT LIFE SCIENCES/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1872,095 8.9%   
Low Rs651,025 6.4%   
Sales per share (Unadj.) Rs364.3492.8 73.9%  
Earnings per share (Unadj.) Rs6.872.6 9.4%  
Cash flow per share (Unadj.) Rs24.594.7 25.9%  
Dividends per share (Unadj.) Rs3.0021.00 14.3%  
Dividend yield (eoy) %2.41.3 176.9%  
Book value per share (Unadj.) Rs164.9862.5 19.1%  
Shares outstanding (eoy) m159.28172.56 92.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.2 10.9%   
Avg P/E ratio x18.421.5 85.6%  
P/CF ratio (eoy) x5.116.5 31.2%  
Price / Book Value ratio x0.81.8 42.2%  
Dividend payout %43.828.9 151.4%   
Avg Mkt Cap Rs m20,061269,194 7.5%   
No. of employees `0006.24.0 154.1%   
Total wages/salary Rs m11,05217,939 61.6%   
Avg. sales/employee Rs Th9,383.021,190.3 44.3%   
Avg. wages/employee Rs Th1,786.94,470.1 40.0%   
Avg. net profit/employee Rs Th176.33,120.0 5.7%   
INCOME DATA
Net Sales Rs m58,03485,037 68.2%  
Other income Rs m1912,338 8.2%   
Total revenues Rs m58,22487,374 66.6%   
Gross profit Rs m5,78634,991 16.5%  
Depreciation Rs m2,8123,817 73.7%   
Interest Rs m3,23720,310 15.9%   
Profit before tax Rs m-7213,202 -0.5%   
Minority Interest Rs m-2861,699 -16.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-100 -2,155.7%   
Tax Rs m6962,281 30.5%   
Profit after tax Rs m1,09012,520 8.7%  
Gross profit margin %10.041.1 24.2%  
Effective tax rate %-965.917.3 -5,589.9%   
Net profit margin %1.914.7 12.8%  
BALANCE SHEET DATA
Current assets Rs m29,28087,590 33.4%   
Current liabilities Rs m38,912185,578 21.0%   
Net working cap to sales %-16.6-115.2 14.4%  
Current ratio x0.80.5 159.4%  
Inventory Days Days8431 271.8%  
Debtors Days Days5148 106.6%  
Net fixed assets Rs m55,712108,523 51.3%   
Share capital Rs m155345 44.8%   
"Free" reserves Rs m20,968148,481 14.1%   
Net worth Rs m26,265148,826 17.6%   
Long term debt Rs m17,169144,957 11.8%   
Total assets Rs m88,606482,394 18.4%  
Interest coverage x1.01.7 59.3%   
Debt to equity ratio x0.71.0 67.1%  
Sales to assets ratio x0.70.2 371.5%   
Return on assets %4.96.8 71.8%  
Return on equity %4.28.4 49.3%  
Return on capital %11.612.0 96.8%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00415,001 146.7%   
Fx outflow Rs m11,7495,150 228.1%   
Net fx Rs m10,2559,851 104.1%   
CASH FLOW
From Operations Rs m8,026-100,393 -8.0%  
From Investments Rs m-1,744-24,202 7.2%  
From Financial Activity Rs m-4,447135,705 -3.3%  
Net Cashflow Rs m1,83411,110 16.5%  

Share Holding

Indian Promoters % 45.6 52.9 86.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.0 217.5%  
FIIs % 21.2 26.6 79.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 16.5 127.9%  
Shareholders   23,815 93,274 25.5%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 22, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS